title: GABA(B) restrains release from singly-evoked GABA terminals.
abstract: Neurotransmitter release regulation is highly heterogeneous across the brain. The fundamental units of release, individual boutons, are difficult to access and poorly understood. Here we directly activated single boutons on mechanically isolated nucleus tractus solitarius (NTS) neurons to record unitary synaptic events under voltage clamp. By scanning the cell surface with a stimulating pipette, we located unique sites that generated evoked excitatory postsynaptic currents (eEPSCs) or evoked inhibitory postsynaptic currents (eIPSCs) events. Stimulus-response relations had abrupt thresholds for all-or-none synaptic events consistent with unitary responses. Thus, irrespective of shock intensity, focal stimulation selectively evoked either eEPSCs or eIPSCs from single retained synaptic boutons and never recruited other synapses. Evoked EPSCs were rarely encountered. Our studies, thus, focused primarily on the more common GABA release. At most locations, shocks often failed to release GABA even at low frequencies (0.075 Hz), and eIPSCs succeeded only on average 2.7±0.7 successful IPSCs per 10 shocks. Activation of eIPSCs decreased spontaneous IPSCs in the same neurons. The GABA(A) receptor antagonist gabazine (3 μM) reversibly blocked eIPSCs as did tetrodotoxin (TTX) (300 nM). The initial low rate of successful eIPSCs decreased further in a use-dependent manner at 0.5 Hz stimulation-depressing 70% in 2 min. The selective GABA(B) receptor antagonist 3-[[(3,4-Dichlorophenyl)methyl]amino]propyl] diethoxymethyl)phosphinic acid (CGP 52432) (5 μM) had three actions: tripling the initial release rate, slowing the use-dependent decline without changing amplitudes, and blocking the shock-related decrease in spontaneous IPSCs. The results suggest strong, surprisingly long-lasting, negative feedback by GABA(B) receptors within single GABA terminals that determine release probability even in isolated terminals.
authors.affiliation: Department of Physiology, School of Medicine, Kyung Hee University, Seoul, 130-701, Korea.
authors.forename: Y-H
authors.initials: YH
authors.lastname: Jin
authors.forename: M C
authors.initials: MC
authors.lastname: Andresen
mesh_terms: D000704:Analysis of Variance; D000818:Animals; D001596:Benzylamines / Q000494:pharmacology; D004558:Electric Stimulation / Q000379:methods; D018691:Excitatory Amino Acid Antagonists / Q000494:pharmacology; D019706:Excitatory Postsynaptic Potentials / Q000187:drug effects / Q000502:physiology; D018756:GABA Antagonists / Q000494:pharmacology; D018698:Glutamic Acid / Q000378:metabolism; D066298:In Vitro Techniques; D053444:Inhibitory Postsynaptic Potentials / Q000187:drug effects / Q000502:physiology; D008297:Male; D009474:Neurons / Q000187:drug effects / Q000378:metabolism*; D010721:Phosphinic Acids / Q000494:pharmacology; D011724:Pyridazines / Q000494:pharmacology; D011810:Quinoxalines / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D011930:Reaction Time / Q000187:drug effects; D026941:Sodium Channel Blockers / Q000494:pharmacology; D017552:Solitary Nucleus / Q000166:cytology*; D013569:Synapses / Q000378:metabolism; D013779:Tetrodotoxin / Q000494:pharmacology; D014633:Valine / Q000031:analogs & derivatives / Q000494:pharmacology; D005680:gamma-Aminobutyric Acid / Q000378:metabolism*
chemical_list: D001596:Benzylamines; D018691:Excitatory Amino Acid Antagonists; D018756:GABA Antagonists; D010721:Phosphinic Acids; D011724:Pyridazines; D011810:Quinoxalines; D026941:Sodium Channel Blockers; C062865:2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline; C083008:CGP 52432; D018698:Glutamic Acid; D013779:Tetrodotoxin; D005680:gamma-Aminobutyric Acid; C056639:2-amino-5-phosphopentanoic acid; C049853:gabazine; D014633:Valine